Cabot (CBT) Research & Development (2009 - 2026)

Cabot (CBT) has 18 years of Research & Development data on file, last reported at $14.0 million in Q1 2026.

• On a quarterly basis, Research & Development fell 6.67% year-over-year to $14.0 million in Q1 2026; TTM through Mar 2026 was $57.0 million, a 8.06% decrease from a year earlier, with the FY2025 full-year figure at $59.0 million, down 6.35% from the prior year.
• Research & Development for Q1 2026 stood at $14.0 million, up from $13.0 million in the prior quarter.
• Over the last five years, Research & Development for CBT reached as high as $17.0 million in Q3 2024 and fell as low as $13.0 million in Q4 2022.
• Historically, Research & Development has averaged $14.6 million across 5 years, with a median of $15.0 million in 2023.
• Across the five-year window, Research & Development climbed 21.43% in 2024 and fell 11.76% in 2025, its largest moves.
• Year by year, Research & Development stood at $13.0 million in 2022, then advanced by 15.38% to $15.0 million in 2023, then declined by 6.67% to $14.0 million in 2024, then slipped by 7.14% to $13.0 million in 2025, then advanced by 7.69% to $14.0 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $14.0 million in Q1 2026, $13.0 million in Q4 2025, and $15.0 million in Q3 2025.